Ritter Pharmaceuticals Names Paul V. Maier to Board of Directors

Ritter Pharmaceuticals brought its board of directors total to six members with the appointment of Paul V. Maier, according to a Business Wire press release.

Maier served as the chief financial officer of life sciences company Sequenom, Inc. for the last five years. He currently serves on the board of directors of International Stem Cell Corporation, Apricus Biosciences, MabVax Therapeutics, and Biological Dynamics.

Read the full press release here.